GINA KOLATA | The Seattle Times

September 23, 2018 at 4:09 pm

Tiny device is a ‘huge advance’ for treatment of severe heart failure

The new trial promises to alter prospects for many people with severe heart failure who had relatively few options. “This will change how we treat...

Nation & World

September 23, 2018 at 3:54 pm

Tiny device is a ‘huge advance’ for treatment of heart failure

In the new study, a device called the MitraClip was used to repair the mitral valve by clipping its two flaps together in the middle....

Nation & World

August 31, 2018 at 5:46 pm

The secret to keeping black men healthy? Maybe black doctors

A study reveals that patients and doctors establish a better rapport when they themselves in each other.

Nation & World

July 27, 2018 at 11:00 pm

Dying organs restored to life in novel experiments

A series of experiments has found that fresh mitochondria can revive flagging cells and enable them to quickly recover.

Nation & World

July 11, 2018 at 8:19 pm

Promising disease treatment using genes and electric shock adds speed, precision

If the technique can be replicated in other labs, it may open up new possibilities for treating an array of diseases, including cancer, infections like...

Nation & World

July 2, 2018 at 4:37 pm

Online gene test finds dangerous mutation, but it may be wrong

As more Americans embrace consumer genetic testing, they are reaching out to other companies for additional analysis. But these are not firms certified to provide...

Nation & World

June 22, 2018 at 4:50 pm

New cancer treatments lie hidden under mountains of paperwork

“Data are trapped,” said Dr. Ned Sharpless, director of the National Cancer Institute. “This is a huge problem. It is phenomenally important.”

June 2, 2018 at 2:32 pm

Antibiotics weren’t used to cure these patients. Fecal bacteria were.

Doctors used so-called fecal transplants to treat a serious gut infection in patients in a small study. The transplants, from healthy donors, were as effective...

Nation & World

This May 10, 2018, image provided by Amgen Inc. shows an artist’s rendering of the packaging for the drug Aimovig, the first in a new class of long-acting drugs designed to prevent chronic migraines. On Thursday, May 17, 2018, the Food and Drug Administration approved the medication, clearing the monthly shot for sale. (Amgen Inc. via AP) NYBZ508 NYBZ508

May 24, 2018 at 1:04 pm

Q&A: Is it a migraine? Many don’t realize what causes their suffering

Migraine is the most disabling neurological disease in the world among people under age 50, beating epilepsy, strokes and chronic back pain. Yet many who...

May 17, 2018 at 8:08 pm

FDA approves drug that prevents migraines

The agency has approved the first drug designed to prevent migraines, a persistent cause of misery worldwide. It’s made by Amgen and Novartis and will...

Nation & World